WP5 Strand B’s Procedure Manual V3 is now available
The third version of the Procedure Manual has been compiled, incorporating comments received from Strand B members and the Stakeholder Advisory Group of WP5. This document describes processes planned for conducting pilot rapid assessments for other technologies such as medical devices, surgical interventions or diagnostics. Since the Procedure Manual is a living document, further changes […]
EUnetHTA facilitates joint response to the public consultation on PAES
EUnetHTA facilitated a joint response of HAS (France), CVZ (Netherlands), and IQWIG (Germany) to the public consultation on PAES. The joint response can be found here: As partners in EUnetHTA with specific distinguished responsibility for HTA processes on national level and as lead participants in relevant EUnetHTA initiatives and concrete cross-border HTA coordination activities, the above […]
The summary from the SF meeting in February is now available
The summary of the latest f-t-f Stakeholder Forum meeting in Brussels 5 February 2013 is now available. EUnetHTA is continuing with its practice of stakeholder involvement in its activities in the new development phase of the Joint Action 2. As was the case already in Joint Action 1, all four stakeholder groups (patients/consumers, providers, payers (statutory health […]
WP5 – Activity update
A fruitful first WP5 JA2 face-to-face meeting was held on 14&15 February 2013 in Diemen (Netherlands). Relevant topics for discussion were the finalisation of the work plan and the organisation of the work in Strand A (pharmaceuticals) and Strand B (other technologies). Currently the procedure manuals for both strands are undergoing consultation by the WP5 […]
WP4 is pleased to announce that the EUnetHTA 1st Core HTA production has started
The topic of this new Core HTA will be “FIT for colorectal cancer screening”; the Core HTA on this topic will be finalised within November 2013. 25 different Agencies from 15 countries will be involved in the collaborative production of Core HTA information on this selected topic. The experience from this Core HTA will be […]
The final version of JA1 WP4 screening model is now available
We are pleased to present the final version of the JA1 WP4 screening model. The model enables production of structured HTA information which can be shared by HTA agencies and adapted into local settings. Objective of the report HTA Core Model for screening technologies is a document that describes a model for assessing screening technologies. […]
The final version of HTA Core Model® and the Methodological Guidelines for Rapid REA of Pharmaceuticals is now available
We are very pleased to present the final version of HTA Core Model® and the Methodological Guidelines for Rapid Relative Effectiveness Assessment (REA) of Pharmaceuticals. They have been produced between January 2010 and February 2013 by Work Package 5 (WP5) of the Joint Action 1 (2010-2012) as part of the objective to “develop HTA tools […]
Ecorys report is now published
1 March 2013, Ecorys submitted the final draft report for an economic and governance analysis of the establishment of a permanent secretariat for the European cooperation on Health Technology Assessment (HTA). The report was commissioned by the Executive Agency for Health and Consumers (EAHC) to prepare for the action stated in Article 15 of Directive […]
DIA’s 25th Annual EuroMeeting, 4-6 March 2013, Amsterdam, The Netherlands
This year the DIA’s Annual EuroMeeting will be held in Amsterdam where it can celebrate its 25th anniversary. The meeting has a global perspective as it attracts well over 3,000 professionals from more than 50 countries from different industries, organisations, academic research centres, regulatory agencies and health ministries. The proposed areas for discussion for the […]
The final version of the JA1 WP5 pilot assessment report is now published
We are pleased to present the final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines. Objective of the pilot rapid assessment The purpose of the pilot was to test the usability of the draft HTA Core Model for Rapid Relative Effectiveness […]
